Found: 24 articles

Article Edition
A.A. Gavrilova, R.A. Bontsevich
Analysis and optimization of approaches to the treatment of community-acquired pneumonia in real clinical practice
№5 / 2022
A.I. Sinopalnikov
Antibiotic therapy for community-acquired pneumonia: what’s new?
№10 / 2021
S.V. Zaitseva, O.V. Zaitseva, E.E. Lokshina
Actual issues of etiology, diagnosis and therapy of community-acquired pneumonia in children
№1 / 2020
R.I. Shaymuratov, A.A. Vizel
Risk factors for fatal outcome in patients with community-acquired pneumonia
№5 / 2019
A.I. Sinopalnikov
Antibiotics and community-acquired low respiratory tract infections. Who for? What preparation?
№5 / 2019
A.A. Zaitsev (1), A.V. Vlasova (2)
COMPLIANCE WITH ANTIBIOTIC THERAPY FOR RESPIRATORY TRACT INFECTIONS
№20 / 2016
I.A. Dronov (1,2), M.D. Shakhnazarova (2)
THE ROLE OF MACROLIDES IN THE TREATMENT OF ACUTE BRONCHITIS AND COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
№1 / 2016
A.A. Vizel, G.V. Lysenko
FEATURES OF THE MANAGEMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN TATARSTAN
№15 / 2014
A.I.Sinopalnikov
COMMUNITY-ACQUIRED PNEUMONIA "NOT RESPONDING" TO ANTIBACTERIAL THERAPY
№15 / 2014
A.I. Sinopalnikov (1), R.S. Kozlov (2), S.A. Rachina (2, 3), N.N. Dekhnich (4)
CURRENT RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
№3 / 2014
A.S. Belevsky
CURRENT POTENTIALS FOR ADJUVANT THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
№6 / 2013
I.V. Leshchenko1,2, Z.D. Bobyleva1, A.V. Krivonogov2
Macrolides In Severe Pneumonia: Why And How To Appoint?
№15 / 2012


Бионика Медиа